Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 67 (3) , 269-274
- https://doi.org/10.1016/0304-3940(86)90320-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatmentNeuroscience Letters, 1986
- Dopaminergic and cholinergic lesions in progressive supranuclear palsyAnnals of Neurology, 1985
- Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markersAnnals of Neurology, 1985
- Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseNeuroscience Letters, 1985
- Does an endogenous methylpyridinium analogue cause Parkinson's disease?Journal of Pharmacy and Pharmacology, 1985
- Parkinson's Disease: An Environmental Cause?Science, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Parkinson's disease: A disorder due to nigral glutathione deficiency?Neuroscience Letters, 1982
- Postmortem Changes of Amino Compounds in Human and Rat BrainJournal of Neurochemistry, 1981